KVUE
KVUE
US49177J1025
Kenvue Inc.
Loading chart...

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Latest News

Related stocks

KMB
KMB • United States
Kimberly-Clark Corporation
97.59 USD
32.39B USD 1Y -18.3%
CHD
CHD • United States
Church & Dwight Company, Inc.
98.11 USD
23.27B USD 1Y +9.9%
CL
CL • United States
Colgate-Palmolive Company
88.27 USD
70.37B USD 1Y +12.9%
EL
EL • United States
Estee Lauder Companies, Inc. (T
98.05 USD
35.53B USD 1Y -1.5%
CLX
CLX • United States
Clorox Company (The)
83.8 USD
10.13B USD 1Y -30.2%
PG
PG • United States
Procter & Gamble Company (The)
151.23 USD
351.52B USD 1Y -0.1%
HEN3.DE
HEN3.DE • Germany
Henkel AG & Co. KGaA I
74.46 EUR
33.78B USD 1Y +5.7%
HEN.DE
HEN.DE • Germany
Henkel AG & Co. KGaA I
68.1 EUR
30.89B USD 1Y +5.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
28.3% p.a.
Max Drawdown (3Y)
-42.3%
Sharpe Ratio (3Y)
-0.22
Beta Factor
0.45
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende